18 Feb 25
As of January 28, 2025, MIR - Medical International Research enters a new chapter in its history with its acquisition by Quadrivio Group, through the Silver Economy Fund - a fund that invests in products and services dedicated to the Silver Age, targeting the 50+ population increasingly focused on health and well-being.
The transaction was carried out in collaboration with a group of co-investors, including Turenne Santé (with the Capital Santé 3 fund as co-sponsor), Eurazeo (through the Nov Santé Actions Non Cotées fund), BNL BNP Paribas, Enthéos, and Muzinich & Co.
With its transition to Quadrivio Group, MIR concludes its journey under the management of Aksìa SGR, which has supported the company’s growth and consolidation in the spirometry sector over the past four years. This step also marks a significant leadership transition. Giovanni Carlino, former CEO of MIR, played a key role in the company’s transformation, leading it to become one of the most prominent players in the industry. His expertise in managing companies with strong internationalization potential has laid the foundation for MIR’s global expansion. Now, the leadership baton passes to Roberta Di Pinto, who, after serving as General Manager, now assumes the role of CEO. She brings a winning combination of deep industry expertise and an in-depth understanding of the company. Roberta Di Pinto acknowledges Aksìa’s role in MIR’s growth and expresses strong confidence in the new partnership with Quadrivio, seeing it as a key step in realizing the company’s full potential: "We are excited to start this new partnership with Quadrivio, the ideal partner to support MIR's growth both in Italy and abroad. MIR still has great potential to express, and we are eager to begin this new chapter in the history of MIR."
The transaction aligns with the fund’s growth strategy, which aims to strengthen its presence in the medical devices sector. "The acquisition of MIR is another important step in the growth of the fund's portfolio, marking a return to investments in the medical devices segment," said Alessandro Binello, CEO of Quadrivio Group. "The company is already a leader in the spirometry sector, and we are confident that, thanks to the team's know-how and management, it will soon become the top global player in the industry."
This transaction represents a key opportunity for MIR to further solidify its position as a global leader in the medical device market for spirometry and respiratory well-being. By combining its 30+ years of expertise with new partnerships, MIR is ready to face future challenges with an even more ambitious picture. The company will continue to invest in Research & Development to deliver increasingly advanced solutions, with the ultimate goal of improving people’s quality of life.
